A target A1C of 7% is a common goal for adults with diabetes, helping reduce long-term complications and improve blood sugar ...

The American College of Physicians (ACP) issued new A1C guidelines for people managing type 2 diabetes, drawing both criticism and praise. Here’s what to know about the new target range and what ...

New findings from the CATALYST study show that the use of mifepristone resulted in improved blood glucose (blood sugar) control and weight reduction in patients with difficult-to-control type 2 ...

Mifepristone reduced A1C by 1.5% as compared to a reduction of 0.2% with placebo. The A1C reductions occurred even as many patients decreased or stopped other diabetes medications, including insulin.

New findings from the CATALYST study show that the use of mifepristone resulted in improved blood glucose (blood sugar) control and weight reduction in patients with difficult-to-control type 2 ...

Further, only one in four young people with type 2 diabetes meet their blood glucose (HbA1c) targets, meaning a higher need for more doctor visits, more medication, and more chance of serious ...

BACKGROUND: Primary aldosteronism (PA), an overt form of renin-independent aldosterone production, leads to a disproportionately high rate of major adverse cardiovascular events (MACEs). Mounting ...

Eli Lilly and Company (NYSE: LLY) Special Call (Lilly Investor Event at American Diabetes Association's (ADA) 85th Scientific Sessions) Conference June 22, 2025 7:30 PM ET Company Participants ...

Find the latest endocrinology and Diabetes news articles, videos, podcasts, and meeting coverage from medical experts and key opinion leaders you trust.